GENE ONLINE|News &
Opinion
Blog

Parkinson’s Disease
Developments in Regenerative Medicine: Gene Delivery Tools and Cell Therapy for Parkinson’s Disease
2023-03-08
Praxis Stock Hits All-Time Low After Phase 2 Tremor Data Released
2023-03-06
Alectos Promised $722 Million in Parkinson’s Collab With Biogen
2022-06-07
NRG Therapeutics Wins £2.68M to Treat Chronic Neurodegenerative Disorders
2022-05-31
Aspen Neuroscience Rakes in $147.5 Million for Parkinson’s Cell Therapy Development
2022-05-10
4D Pharma Cleared to Investigate Healing the Brain through the Gut
2022-03-16
Abbvie Acquires Neuroscience Company Syndesi for $1 Billion
2022-03-02
Sanofi Licenses ABL Bio’s Bispecific Antibody for Parkinson’s Disease
2022-01-13
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
South Korea’s D&D Pharmatech Secures $51M Series C, Eyes 2022 IPO
2021-10-20
M&A
Supernus Invests $400 Million to Acquire New Parkinson’s Assets from Adamas
2021-10-12
Voyager Encounters Regulatory Bump in Parkinson’s Trial
2020-12-25
First of its Kind Therapy for Parkinson’s Disease Advances to Phase 2b Trials
2020-10-22
Exploring RNA Splicing as a Potential New Drug Avenue for Parkinson’s Disease
2020-09-16
TET2 – A Master Switch to Turn off Parkinson Disease Symptoms
2020-08-22
1 2
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top